Pharma

Bringing The Drama To Life, Pharma Uses Thousands Of Pages Of Government And Corporate Archives, Dozens Of Hours Of Interviews, And Fbi Files To Trace The Arc Of A Global Industry—From Groundbreaking Breakthroughs To The Corners Where Calculated Risk And Corporate Structure Shaped Public Policy. The Narrative Follows Brave Whistleblowers And Vigilant Regulators As They Confront Executives Driven By Profit, Weaving The Sackler Saga Into The Larger Story Of An Industry That Sits At The Intersection Of Healing And Harm.

Written In A Clear, Accessible Voice, Pharma Turns Intricate Policy Debates Into A Compelling, Page-Turning Investigation. You’Ll Encounter Vivid Profiles, Crisp Timelines, And Case Studies That Illuminate How Drug Pricing, Safety Recalls, And Prescribing Practices Affect Families Across The Country. The Book Doesn’T Shy Away From Tough Questions About Regulation, Accountability, And The Cost Of Progress, Inviting Readers To Think Critically About How Medicine, Markets, And Public Trust Intersect.

• Deep Dive Into The Industry’S Pivotal Breakthroughs And Controversial Moments
• The Sackler Family Saga And Its Connection To The Opioid Crisis
• Insider Perspectives From Regulators, Whistleblowers, And Executives
• Accessible Explanations Of Drug Pricing, Safety Recalls, And Policy
• Archival Research, Interviews, And Fbi Files That Ground The Narrative
• Engaging Storytelling That Connects Science, Business, And Public Health

After Finishing Pharma, Readers Gain A Clearer Understanding Of How Profits Intersect With Patients’ Wellbeing, Plus A Sober Call For Accountability And Reform. It Leaves You Thinking Differently About Trust In Medicine And The Systems That Regulate It, And It Reminds Us That Responsible Innovation Must Prioritize People Over Profits.